IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
42 hedge funds and large institutions have $95.7M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
-3
Holders Change %
-6.67%
% of All Funds
0.66%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
5
Increased
13
Reduced
12
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
DA
DCF Advisers
Greenwich,
Connecticut
|
$2.34M |
2 |
Vanguard Group
Malvern,
Pennsylvania
|
$3.39M |
3 |
Renaissance Technologies
New York
|
$211K |
4 |
Geode Capital Management
Boston,
Massachusetts
|
$1.03M |
5 |
State Street
Boston,
Massachusetts
|
$1.15M |